174
Views
3
CrossRef citations to date
0
Altmetric
Review

Takotsubo Syndrome: Optimizing Care with a Multidisciplinary Approach

ORCID Icon & ORCID Icon
Pages 2487-2499 | Published online: 10 Sep 2021

References

  • Sato H, Tateishi H, Uchida T, et al. Clinical aspect of myocardial injury: from ischemia to heart failure. Kagaku Hyoronsha. 1990;2:55–64.
  • Templin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 2015;373(10):929–938. doi:10.1056/NEJMoa1406761
  • Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol. 2001;38(1):11–18. doi:10.1016/S0735-1097(01)01316-X
  • Finsterer J, Wahbi K. CNS disease triggering Takotsubo stress cardiomyopathy. Int J Cardiol. 2014;177(2):322–329. doi:10.1016/j.ijcard.2014.08.101
  • Sattler K, El-Battrawy I, Lang S, et al. Prevalence of cancer in Takotsubo cardiomyopathy: short and long-term outcome. Int J Cardiol. 2017;238:159–165. doi:10.1016/j.ijcard.2017.02.093
  • Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol. 2015;12(7):387–397. doi:10.1038/nrcardio.2015.39
  • Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J. 2012;164(1):66–71 e1. doi:10.1016/j.ahj.2012.03.020
  • Schneider B, Athanasiadis A, Stollberger C, et al. Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol. 2013;166(3):584–588. doi:10.1016/j.ijcard.2011.11.027
  • Topal Y, Topal H, Dogan C, Tiryaki SB, Biteker M. Takotsubo (stress) cardiomyopathy in childhood. Eur J Pediatr. 2020;179(4):619–625. doi:10.1007/s00431-019-03536-z
  • Sharkey SW, Windenburg DC, Lesser JR, et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010;55(4):333–341. doi:10.1016/j.jacc.2009.08.057
  • Urbinati A, Pellicori P, Guerra F, Capucci A, Clark AL. Takotsubo syndrome in the paediatric population: a case report and a systematic review. J Cardiovasc Med. 2017;18(4):262–267. doi:10.2459/JCM.0000000000000446
  • Singh K, Carson K, Usmani Z, Sawhney G, Shah R, Horowitz J. Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy. Int J Cardiol. 2014;174(3):696–701. doi:10.1016/j.ijcard.2014.04.221
  • El‐Battrawy I, Santoro F, Stiermaier T, et al. Incidence and clinical impact of recurrent Takotsubo syndrome: results from the GEIST registry. J Am Heart Assoc. 2019;8(9):e010753. doi:10.1161/JAHA.118.010753
  • Kato K, Di Vece D, Cammann VL, et al. Takotsubo Recurrence: morphological Types and Triggers and Identification of Risk Factors. J Am Coll Cardiol. 2019;73(8):982–984. doi:10.1016/j.jacc.2018.12.033
  • Arcari L, Cacciotti L, Limite LR, et al. Clinical characteristics of patients with takotsubo syndrome recurrence: an observational study with long-term follow-up. Int J Cardiol. 2021;329:23–27. doi:10.1016/j.ijcard.2020.12.047
  • Ghadri J-R, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032–2046. doi:10.1093/eurheartj/ehy076
  • Giavarini A, Chedid A, Bobrie G, Plouin PF, Hagege A, Amar L. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart. 2013;99(19):1438–1444. doi:10.1136/heartjnl-2013-304073
  • Finsterer J, Stöllberger C. Central nervous system (CNS) disease triggering Takotsubo syndrome. International Cardiovascular Forum Journal. 2016;5. doi:10.17987/icfj.v5i0.183
  • Suzuki H, Matsumoto Y, Kaneta T, et al. Evidence for brain activation in patients with takotsubo cardiomyopathy. Circ J. 2014;78(1):256–258. doi:10.1253/circj.cj-13-1276
  • Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol. 2009;53(15):1320–1325. doi:10.1016/j.jacc.2009.02.020
  • Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548. doi:10.1056/NEJMoa043046
  • Kume T, Kawamoto T, Okura H, et al. Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ J. 2008;72(1):106–108. doi:10.1253/circj.72.106
  • Ortak J, Khattab K, Barantke M, et al. Evolution of cardiac autonomic nervous activity indices in patients presenting with transient left ventricular apical ballooning. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S21–5. doi:10.1111/j.1540-8159.2008.02221.x
  • Burgdorf C, von Hof K, Schunkert H, Kurowski V. Regional alterations in myocardial sympathetic innervation in patients with transient left-ventricular apical ballooning (Tako-Tsubo cardiomyopathy). J Nucl Cardiol. 2008;15(1):65–72. doi:10.1016/j.nuclcard.2007.08.005
  • Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab. 1999;84(2):606–610. doi:10.1210/jcem.84.2.5447
  • Sung BH, Ching M, Izzo JL, Dandona P, Wilson MF. Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women. J Hypertens. 1999;17(4):523–528. doi:10.1097/00004872-199917040-00010
  • Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018;39(22):2032–2046. doi:10.1093/eurheartj/ehy076
  • Kurisu S, Inoue I, Kawagoe T, et al. Time course of electrocardiographic changes in patients with tako-tsubo syndrome: comparison with acute myocardial infarction with minimal enzymatic release. Circ J. 2004;68(1):77–81. doi:10.1253/circj.68.77
  • Akashi YJ, Musha H, Nakazawa K, Miyake F. Plasma brain natriuretic peptide in takotsubo cardiomyopathy. QJM. 2004;97(9):599–607. doi:10.1093/qjmed/hch094
  • Nef HM, Mollmann H, Hilpert P, et al. Sympathoadrenergic overstimulation in Tako-Tsubo cardiomyopathy triggered by physical and emotional stress. Int J Cardiol. 2008;130(2):266–268. doi:10.1016/j.ijcard.2007.05.119
  • Pilgrim TM, Wyss TR. Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol. 2008;124(3):283–292. doi:10.1016/j.ijcard.2007.07.002
  • Pirlet C, Pierard L, Legrand V, Gach O. Ratio of high-sensitivity troponin to creatine kinase-MB in takotsubo syndrome. Int J Cardiol. 2017;243:300–305. doi:10.1016/j.ijcard.2017.05.107
  • Dagrenat C, Von Hunolstein JJ, Matsushita K, et al. Value of Cardiac Biomarkers in the Early Diagnosis of Takotsubo Syndrome. J Clin Med. 2020;9(9):2985. doi:10.3390/jcm9092985
  • Fröhlich GM, Schoch B, Schmid F, et al. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. Int J Cardiol. 2012;154(3):328–332. doi:10.1016/j.ijcard.2011.09.077
  • Pelliccia F, Parodi G, Greco C, et al. Comorbidities frequency in Takotsubo syndrome: an international collaborative systematic review including 1109 patients. Am J Med. 2015;128(6):654e11–9. doi:10.1016/j.amjmed.2015.01.016
  • Gopalakrishnan P, Zaidi R, Sardar MR. Takotsubo cardiomyopathy: pathophysiology and role of cardiac biomarkers in differential diagnosis. World J Cardiol. 2017;9(9):723–730. doi:10.4330/wjc.v9.i9.723
  • Citro R, Okura H, Ghadri JR, et al. Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE). Eur Heart J Cardiovascular Imaging. 2020;21(11):1184–1207. doi:10.1093/ehjci/jeaa149
  • Elesber AA, Prasad A, Bybee KA, et al. Transient cardiac apical ballooning syndrome: prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol. 2006;47(5):1082–1083. doi:10.1016/j.jacc.2005.12.004
  • Tamborini G, Piazzese C, Lang RM, et al. Feasibility and Accuracy of Automated Software for Transthoracic Three-Dimensional Left Ventricular Volume and Function Analysis: comparisons with Two-Dimensional Echocardiography, Three-Dimensional Transthoracic Manual Method, and Cardiac Magnetic Resonance Imaging. J Am Soc Echocardiogr. 2017;30(11):1049–1058. doi:10.1016/j.echo.2017.06.026
  • Nagata Y, Wu VC, Kado Y, et al. Prognostic Value of Right Ventricular Ejection Fraction Assessed by Transthoracic 3D Echocardiography. Circ Cardiovasc Imaging. 2017;10(2):e005384. doi:10.1161/CIRCIMAGING.116.005384
  • Hwang HJ, Sohn IS. A case of biventricular involvement of Takotsubo cardiomyopathy: 3D echocardiographic imaging. J Echocardiogr. 2014;12(1):48–49. doi:10.1007/s12574-013-0200-2
  • Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008;155(3):408–417. doi:10.1016/j.ahj.2007.11.008
  • Napp LC, Cammann VL, Jaguszewski M, et al. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. Eur Heart J. 2020;41(34):3255–3268. doi:10.1093/eurheartj/ehaa210
  • Kato K, Kitahara H, Fujimoto Y, et al. Prevalence and Clinical Features of Focal Takotsubo Cardiomyopathy. Circ J. 2016;80(8):1824–1829. doi:10.1253/circj.CJ-16-0360
  • Eitel I, von Knobelsdorff-brenkenhoff F, Bernhardt P, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011;306(3):277–286. doi:10.1001/jama.2011.992
  • Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8–27. doi:10.1002/ejhf.424
  • Scantlebury DC, Prasad A. Diagnosis of takotsubo cardiomyopathy–Mayo Clinic criteria. Circ J. 2014;1:CJ-14-0859.
  • Ghadri JR, Cammann VL, Jurisic S, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017;19(8):1036–1042. doi:10.1002/ejhf.683
  • Kato K, Sakai Y, Ishibashi I, Himi T, Fujimoto Y, Kobayashi Y. Predictors of in-hospital cardiac complications in patients with Takotsubo syndrome. Heart Vessels. 2018;33(10):1214–1219. doi:10.1007/s00380-018-1172-y
  • Kato K, Lyon AR, Ghadri JR, Templin C. Takotsubo syndrome: aetiology, presentation and treatment. Heart. 2017;103(18):1461–1469. doi:10.1136/heartjnl-2016-309783
  • Madias C, Fitzgibbons TP, Alsheikh-Ali AA, et al. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes. Heart Rhythm. 2011;8(4):555–561. doi:10.1016/j.hrthm.2010.12.012
  • Santoro F, Ieva R, Ferraretti A, et al. Hemodynamic Effects, Safety, and Feasibility of Intravenous Esmolol Infusion During Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction: results From A Multicenter Registry. Cardiovasc Ther. 2016;34(3):161–166. doi:10.1111/1755-5922.12182
  • Paur H, Wright PT, Sikkel MB, et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi–dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126(6):697–706. doi:10.1161/CIRCULATIONAHA.112.111591
  • De Santis V, Vitale D, Tritapepe L, Greco C, Pietropaoli P. Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome. Ann Intern Med. 2008;149(5):365–367. doi:10.7326/0003-4819-149-5-200809020-00028
  • Isogai T, Matsui H, Tanaka H, Fushimi K, Yasunaga H. Early β-blocker use and in-hospital mortality in patients with Takotsubo cardiomyopathy. Heart. 2016;102(13):1029–1035. doi:10.1136/heartjnl-2015-308712
  • Kurisu S, Inoue I, Kawagoe T, et al. Incidence and treatment of left ventricular apical thrombosis in Tako-tsubo cardiomyopathy. Int J Cardiol. 2011;146(3):e58–60. doi:10.1016/j.ijcard.2008.12.208
  • Bietry R, Reyentovich A, Katz SD. Clinical management of takotsubo cardiomyopathy. Heart Fail Clin. 2013;9(2):177–186. doi:10.1016/j.hfc.2012.12.003
  • Kurisu S, Kihara Y. Clinical management of takotsubo cardiomyopathy. Circ J. 2014;78(7):1559–1566. doi:10.1253/circj.CJ-14-0382
  • Ding KJ, Cammann VL, Szawan KA, et al. Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: insights From the International Takotsubo Registry. Arterioscler Thromb Vasc Biol. 2020;40(1):279–287. doi:10.1161/ATVBAHA.119.313491
  • Kurisu S, Inoue I, Kawagoe T, et al. Torsade de pointes associated with bradycardia and takotsubo cardiomyopathy. Can J Cardiol. 2008;24(8):640–642. doi:10.1016/s0828-282x(08)70653-6
  • Purvis JA, Cunningham EL, McGlinchey PG, Barr SH. Drugs, electrolytes and tako-tsubo cardiomyopathy: triple aetiology of acquired long QT syndrome and torsades de pointes. Ulster Med J. 2009;78(3):188–189.
  • Santoro F, Ieva R, Musaico F, et al. Lack of efficacy of drug therapy in preventing Takotsubo cardiomyopathy recurrence: a meta‐analysis. Clin Cardiol. 2014;37(7):434–439. doi:10.1002/clc.22280
  • Brunetti ND, Santoro F, De Gennaro L, et al. Combined therapy with beta-blockers and ACE-inhibitors/angiotensin receptor blockers and recurrence of Takotsubo (stress) cardiomyopathy: a meta-regression study. Int J Cardiol. 2017;230:281–283. doi:10.1016/j.ijcard.2016.12.124
  • Gelow J, Kruer M, Yadav V, Kaul S. Apical ballooning resulting from limbic encephalitis. Am J Med. 2009;122(6):583–586. doi:10.1016/j.amjmed.2008.12.016
  • Kakinuma Y, Kimura T, Sakae Y, Kubota S, Ono K, Kinno R. Takotsubo syndrome associated with autoimmune limbic encephalitis: a case report. BMC Cardiovasc Disord. 2021;21(1):86. doi:10.1186/s12872-020-01789-3
  • Samuels MA. The brain-heart connection. Circulation. 2007;116(1):77–84. doi:10.1161/CIRCULATIONAHA.106.678995
  • Hiestand T, Hanggi J, Klein C, et al. Takotsubo Syndrome Associated With Structural Brain Alterations of the Limbic System. J Am Coll Cardiol. 2018;71(7):809–811. doi:10.1016/j.jacc.2017.12.022
  • Templin C, Hanggi J, Klein C, et al. Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome. Eur Heart J. 2019;40(15):1183–1187. doi:10.1093/eurheartj/ehz068
  • de Chazal HM, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(16):1955–1971. doi:10.1016/j.jacc.2018.07.072
  • Ghadri JR, Kato K, Cammann VL, et al. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol. 2018;72(8):874–882. doi:10.1016/j.jacc.2018.06.016
  • Montone RA, Niccoli G, Del Buono MG, Galiuto L, Crea F. Emotional versus physical Takotsubo syndrome: two faces of the same medal or two different syndromes? Prog Cardiovasc Dis. 2020;S0033-0620(20):30142. doi:10.1016/j.pcad.2020.07.005
  • Ghadri JR, Sarcon A, Diekmann J, et al. Happy heart syndrome: role of positive emotional stress in takotsubo syndrome. Eur Heart J. 2016;37(37):2823–2829. doi:10.1093/eurheartj/ehv757
  • Nayeri A, Rafla-Yuan E, Krishnan S, et al. Psychiatric Illness in Takotsubo (Stress) Cardiomyopathy: a Review. Psychosomatics. 2018;59(3):220–226. doi:10.1016/j.psym.2018.01.011
  • Summers MR, Lennon RJ, Prasad A. Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential pre-disposing factors? J Am Coll Cardiol. 2010;55(7):700–701. doi:10.1016/j.jacc.2009.10.031
  • Corrigan III FE, Kimmel MC, Jayaram G. Four cases of takotsubo cardiomyopathy linked with exacerbations of psychiatric illness. Innov Clin Neurosci. 2011;8(7):50.
  • Yaqub Y, Jenkins LA, Nugent KM, Chokesuwattanaskul W. Postpartum depression and apical ballooning syndrome (takotsubo syndrome). J Obstet Gynaecol Can. 2009;31(8):736–739. doi:10.1016/S1701-2163(16)34279-7
  • Maldonado JR, Pajouhi P, Witteles R. Case reports broken heart syndrome (takotsubo cardiomyopathy) triggered by acute mania: a review and case report. Psychosomatics. 2013;54(1):74–79. doi:10.1016/j.psym.2012.03.009
  • Christoph M, Ebner B, Stolte D, et al. Broken heart syndrome: tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur Neuropsychopharmacol. 2010;20(8):594–597. doi:10.1016/j.euroneuro.2010.03.009
  • Selke KJ, Dhar G, Cohn JM. Takotsubo cardiomyopathy associated with titration of duloxetine. Tex Heart Inst J. 2011;38(5):573–576.
  • Naguy A, Al-Mutairi H, Al-Tajali A. Atomoxetine-related Takotsubo Cardiomyopathy. J Psychiatr Pract. 2016;22(3):232–233. doi:10.1097/PRA.0000000000000152
  • Kitami M, Oizumi H, Kish SJ, Furukawa Y. Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: a case report. J Clin Psychopharmacol. 2014;34(3):410–411. doi:10.1097/JCP.0b013e3182a95a27
  • Narayanan A, Russell MD, Sundararaman S, Shankar KK, Artman B. Takotsubo cardiomyopathy following electroconvulsive therapy: an increasingly recognised phenomenon. BMJ Case Rep. 2014;2014:bcr2014206816. doi:10.1136/bcr-2014-206816
  • Nayeri A, Rafla-Yuan E, Farber-Eger E, et al. Pre-existing psychiatric illness is associated with increased risk of recurrent Takotsubo cardiomyopathy. Psychosomatics. 2017;58(5):527–532. doi:10.1016/j.psym.2017.04.008
  • Burgdorf C, Kurowski V, Bonnemeier H, Schunkert H, Radke PW. Long‐term prognosis of the transient left ventricular dysfunction syndrome (Tako‐Tsubo cardiomyopathy): focus on malignancies. Eur J Heart Fail. 2008;10(10):1015–1019. doi:10.1016/j.ejheart.2008.07.008
  • Desai R, Abbas SA, Goyal H, et al. Frequency of Takotsubo Cardiomyopathy in Adult Patients Receiving Chemotherapy (from a 5-Year Nationwide Inpatient Study). Am J Cardiol. 2019;123(4):667–673. doi:10.1016/j.amjcard.2018.11.006
  • Desai A, Noor A, Joshi S, Kim AS. Takotsubo cardiomyopathy in cancer patients. Cardio-Oncology. 2019;5(1):1–16. doi:10.1186/s40959-019-0042-9
  • Madias JE. What is/are the trigger (s) of takotsubo syndrome in cancer patients receiving chemotherapy? Int J Cardiol. 2016;222:253. doi:10.1016/j.ijcard.2016.07.246
  • Kinno R, Kii Y, Uchiyama M, Owan Y, Yamazaki T, Fukui T. 5-fluorouracil-induced leukoencephalopathy with acute stroke-like presentation fulfilling criteria for recombinant tissue plasminogen activator therapy. J Stroke Cerebrovasc Dis. 2014;23(2):387–389. doi:10.1016/j.jstrokecerebrovasdis.2013.01.014
  • van Kuilenburg AB. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. Eur J Cancer. 2004;40(7):939–950. doi:10.1016/j.ejca.2003.12.004
  • Knott K, Starling N, Rasheed S, et al. A case of Takotsubo syndrome following 5-fluorouracil chemotherapy. Int J Cardiol. 2014;177(2):e65–7. doi:10.1016/j.ijcard.2014.09.154
  • Stewart T, Pavlakis N, Ward M. Cardiotoxicity with 5‐fluorouracil and capecitabine: more than just vasospastic angina. Intern Med J. 2010;40(4):303–307. doi:10.1111/j.1445-5994.2009.02144.x
  • Franco TH, Khan A, Joshi V, Thomas B. Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer. Ther Clin Risk Manag. 2008;4(6):1367–1370. doi:10.2147/tcrm.s3960
  • Bhakta S, Flick SM, Cooney MM, et al. Myocardial Stunning Following Combined Modality Combretastatin‐Based Chemotherapy: two Case Reports and Review of the Literature. Clin Cardiol. 2009;32(12):E80–E84. doi:10.1002/clc.20685
  • Ng KH, Dearden C, Gruber P. Rituximab-induced Takotsubo syndrome: more cardiotoxic than it appears? Case Reports. 2015;2015:bcr2014208203.
  • Numico G, Sicuro M, Silvestris N, et al. Takotsubo syndrome in a patient treated with sunitinib for renal cancer. J Clin Oncol. 2012;30(24):e218–20. doi:10.1200/JCO.2012.42.4911
  • Geisler BP, Raad RA, Esaian D, Sharon E, Schwartz DR. Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome. J Immunother Cancer. 2015;3(1):4. doi:10.1186/s40425-015-0048-2
  • Kato K, Cammann VL, Napp LC, et al. Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry. ESC Heart Fail. 2021;8(3):1924–1932. doi:10.1002/ehf2.13165
  • Mathew B, Villarreal D. Two unusual cases of Takotsubo cardiomyopathy presenting with sudden cardiac death. Am J Med Sci. 2009;337(6):473–475. doi:10.1097/MAJ.0b013e3181956f49
  • Brezina P, Isler CM. Takotsubo cardiomyopathy in pregnancy. Obstet Gynecol. 2008;112(2 Pt 2):450–452. doi:10.1097/AOG.0b013e3181662cfe
  • Hassan S. Takotsubo syndrome triggered by acute coronary syndrome in a cohort of 20 patients: an often missed diagnosis. Int J Cardiol Res. 2015;2(2):28–33.
  • Sandoval Y, Januzzi JL, Jaffe AS. Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76(10):1244–1258. doi:10.1016/j.jacc.2020.06.068
  • Giustino G, Pinney SP, Lala A, et al. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar. J Am Coll Cardiol. 2020;76(17):2011–2023. doi:10.1016/j.jacc.2020.08.059
  • Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: a Review. JAMA Cardiol. 2020;5(7):831–840. doi:10.1001/jamacardio.2020.1286
  • Giustino G, Croft LB, Oates CP, et al. Takotsubo Cardiomyopathy in COVID-19. J Am Coll Cardiol. 2020;76(5):628–629. doi:10.1016/j.jacc.2020.05.068
  • Moady G, Atar S. Takotsubo syndrome during the COVID-19 pandemic, state-of -the- art review. CJC Open. 2021. doi:10.1016/j.cjco.2021.05.011